
The Ongoing Challenge of Antimicrobial Selection for Bloodstream Infections
Sepsis and bloodstream infections (BSIs) are common, causing millions of deaths each year. Tune in to learn from Jasmine R. Marcelin, MD, FACP, FIDSA, how inadequate antibiotic coverage can be linked to increased mortality and length of stay and how unnecessary broad-spectrum antibiotics can drive antimicrobial resistance.
Decera Clinical Education Infectious Disease Podcast · Jasmine R. Marcelin MD FACP FIDSA
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Sepsis and bloodstream infections (BSIs) are common and cause millions of deaths each year, with a disproportionate burden in low-income and middle-income countries. Tune in to learn from Jasmine R. Marcelin, MD, FACP, FIDSA, how inadequate antibiotic coverage can be linked to increased mortality and length of stay and how unnecessary broad-spectrum antibiotics can drive antimicrobial resistance. Topics covered include:
- The worldwide burden of sepsis and BSIs
- The ongoing threat of antimicrobial resistance
- US and global health disparities in sepsis, BSI, and antimicrobial resistance
- Barriers toward optimizing antibiotic use in BSIs
Presenter:
Jasmine R. Marcelin, MD, FACP, FIDSA
Associate Professor, Infectious Disease
Associate Medical Director, Antimicrobial Stewardship Program
Vice Chair for Belonging and Community Engagement, Department of Internal Medicine
Co-Director, Digital Innovation & Social Media Strategy, Division of Infectious Diseases
University of Nebraska Medical Center
Omaha, Nebraska
Link to full program and downloadable slides:
https://bit.ly/4inoXCx
Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.